Search results
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 3 days agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 7 days agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 9 hours agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 1 day agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent ...
Experts Share How to Do a Hot Oil Treatment for Hair at Home
Prevention via Yahoo News· 3 days agoIt can also just... feel nice. Boost blood flow to scalp You may have heard that hot oil treatments...
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 6 days agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 3 days agoA decision on approval is expected in the fourth quarter of 2024.
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 15 hours agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 6 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
WTNH-TV New Haven· 4 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...